These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18337384)

  • 1. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Canton E
    J Clin Microbiol; 2008 May; 46(5):1793-803. PubMed ID: 18337384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A; Canton E; Gibbs D; Wang A
    J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of 100 filamentous fungi: comparison of two diffusion methods, Neo-Sensitabs and E-test, for amphotericin B, caspofungin, itraconazole, voriconazole and posaconazole.
    Colosi IA; Faure O; Dessaigne B; Bourdon C; Lebeau B; Colosi HA; Pelloux H
    Med Mycol; 2012 May; 50(4):378-85. PubMed ID: 21981028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
    Espinel-Ingroff A
    J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi.
    Espinel-Ingroff A; Canton E; Fothergill A; Ghannoum M; Johnson E; Jones RN; Ostrosky-Zeichner L; Schell W; Gibbs DL; Wang A; Turnidge J
    J Clin Microbiol; 2011 Jul; 49(7):2568-71. PubMed ID: 21543581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
    Messer SA; Diekema DJ; Hollis RJ; Boyken LB; Tendolkar S; Kroeger J; Pfaller MA
    J Clin Microbiol; 2007 Apr; 45(4):1322-4. PubMed ID: 17267623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
    Pujol I; Pastor FJ; dos Santos Lazéra M; Guarro J
    Rev Iberoam Micol; 2008 Dec; 25(4):215-20. PubMed ID: 19071889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.
    Torres-Narbona M; Guinea J; Martínez-Alarcón J; Peláez T; Bouza E
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1126-9. PubMed ID: 17194821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Diekema DJ; Messer SA; Hollis RJ; Jones RN; Pfaller MA
    J Clin Microbiol; 2003 Aug; 41(8):3623-6. PubMed ID: 12904365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.
    López-Oviedo E; Aller AI; Martín C; Castro C; Ramirez M; Pemán JM; Cantón E; Almeida C; Martín-Mazuelos E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1108-11. PubMed ID: 16495281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi.
    Pinto E; Lago M; Branco L; Vale-Silva LA; Pinheiro MD
    Mycopathologia; 2014 Apr; 177(3-4):157-66. PubMed ID: 24570038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Carrillo-Muñoz AJ; Quindós G; del Valle O; Santos P; Giusiano G; Ezkurra PA; Estivill MD; Casals JB
    Chemotherapy; 2008; 54(1):38-42. PubMed ID: 18073469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
    Lacroix C; de Chauvin MF
    J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Morace G; Drago M; Scaltrito MM; Conti S; Fanti F; Polonelli L;
    J Chemother; 2007 Oct; 19(5):508-13. PubMed ID: 18073149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.